Hillsdale Investment Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Hillsdale Investment Management’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-86,139	Closed	-$749K	–	582
2018 Q2	$749K	Buy	86,139 +40,000	+87%	+$360K	0.09%	172
2018 Q1	$468K	Buy	+46,139	New	+$388K	0.07%	183

Hillsdale Investment Management's JNP Position: Q3 2018 in Review

Hillsdale Investment Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 86,139 shares — an estimated $749K sold.

Hillsdale Investment Management first reported a position in JNP in Q1 2018 and held it in 2 quarters. The position peaked at $749K in Q2 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

Hillsdale Investment Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Hillsdale Investment Management sold 86,139 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $749K.
Hillsdale Investment Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 2 quarters.
Hillsdale Investment Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $749K in Q2 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Hillsdale Investment Management's 13F filing for Q3 2018, filed 9 Nov 2018.